Skip to main content
Burak Ozpineci is a globally recognized leader in power electronics research. He was named an ORNL Corporate Fellow in fall 2021. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Burak Ozpineci started out at ORNL working on a novel project: introducing silicon carbide into power electronics for more efficient electric vehicles. Twenty years later, the car he drives contains those same components.

ORNL’s Larry York studies how plant root traits contribute to crop productivity. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Biologist Larry York’s fascination with plant roots has spurred his research across four continents and inspired him to create accessible tools that enable others to explore the underground world.

Carrie Eckert

Carrie Eckert applies her skills as a synthetic biologist at ORNL to turn microorganisms into tiny factories that produce a variety of valuable fuels, chemicals and materials for the growing bioeconomy.

Erdem Asa is leveraging his power electronics expertise to adapt ORNL’s wireless charging technology to unmanned aerial vehicles. Credit: Erdem Asa/ORNL, U.S. Dept. of Energy

Having co-developed the power electronics behind ORNL’s compact, high-level wireless power technology for automobiles, Erdem Asa is looking to the skies to apply the same breakthrough to aviation.

Environmental scientist John Field uses ecosystem models to analyze sustainable methods for growing crops such as switchgrass. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

For ORNL environmental scientist and lover of the outdoors John Field, work in ecosystem modeling is a profession with tangible impacts.

ORNL used novel additive manufacturing techniques to 3D print channel fasteners for Framatome’s boiling water reactor fuel assembly. Four components, like the one shown here, were installed at the TVA Browns Ferry nuclear plant. Credit: Framatome

Four first-of-a-kind 3D-printed fuel assembly brackets, produced at the Department of Energy’s Manufacturing Demonstration Facility at Oak Ridge National Laboratory, have been installed and are now under routine operating

ORNL metabolic engineer Adam Guss develops genetic tools to modify microbes that can perform a range of processes needed to create sustainable biofuels and bioproducts. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

As a metabolic engineer at Oak Ridge National Laboratory, Adam Guss modifies microbes to perform the diverse processes needed to make sustainable biofuels and bioproducts.

Ross Wang is leveraging his expertise in civil engineering, transportation systems, data analytics, and modeling and simulation in a variety of mobility projects at ORNL, including unsnarling traffic on some of the nation’s most congested roadways. Credit: ORNL/U.S. Dept. of Energy

Ross Wang has been intent on resolving traffic jams since he rode a city bus every day through 40 minutes of traffic to get to his elementary school. That daily journey left an impression that would shape his career.

ORNL’s Josh Michener, a microbiologist and metabolic engineer, led the discovery of a useful new enzyme that breaks down stubborn bonds in lignin, a polymer found in plants that typically becomes waste during bioconversion. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

In a step toward increasing the cost-effectiveness of renewable biofuels and bioproducts, scientists at ORNL discovered a microbial enzyme that degrades tough-to-break bonds in lignin, a waste product of biorefineries.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.